Africa-linked IPOs are having a strong year. Seven companies with significant African operations have raised at least $100 million via IPOs so far this year, totaling $2.6 billion in proceeds, more than each of the past five years. The pipeline is...read more
Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, announced terms for its IPO on Tuesday. The South San Francisco, CA-based company plans to raise $250 million by offering 14.7 million shares at a price...read more
Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO on Tuesday. The Miami, FL-based company now plans to raise $50 million by offering 3.2 million shares at a price range of $14 to $17....read more
Africa-linked IPOs pick up steam in 2026
Africa-linked IPOs are having a strong year. Seven companies with significant African operations have raised at least $100 million via IPOs so far this year, totaling $2.6 billion in proceeds, more than each of the past five years. The pipeline is...read more
Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO
Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, announced terms for its IPO on Tuesday. The South San Francisco, CA-based company plans to raise $250 million by offering 14.7 million shares at a price...read more
Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO
Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO on Tuesday. The Miami, FL-based company now plans to raise $50 million by offering 3.2 million shares at a price range of $14 to $17....read more